Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest X-Change Corp. Stories

2013-08-21 16:25:38

Expanding to Ten or More Additional Patient-Driven Facilities Within Legal Regulatory Environments Throughout the United States, Offering the Company Multiple Opportunities to Develop and Market Proprietary Cannabinoid Products for Effective Patient Treatment COLORADO SPRINGS, Colo., Aug. 21, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health and wellness solutions, is pleased to announce the signing...

2013-08-20 12:26:36

Bringing Proprietary Cannabinoid-based Products and Formulations to Market in State-Approved Regulatory Environments COLORADO SPRINGS, Colo., Aug. 20, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health and wellness solutions, entered into a multi-year, strategic growth agreement with Medicine Dispensing Systems, a wholly owned subsidiary of Medbox, Inc., a publicly traded company, to provide its...

2013-08-06 12:27:06

COLORADO SPRINGS, Colo., Aug. 6, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company specializing primarily in cannabinoid formulation-based health and wellness solutions is excited to see expansion of its target market into Uruguay. After jumping the most difficult hurdle in the country's lower legislative body, national legalization is expected to be signed into law in October. This unprecedented national move is consistent with the rapid opening of...

2013-07-10 12:27:54

Bringing Proprietary Cannabinoid-based Products Including Medical Cannabis to Market by Providing Licensees Expert Lead Management in State-Approved Regulatory Environments COLORADO SPRINGS, Colo., July 10, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health and wellness solutions, in a strategic growth initiative announces advanced negotiations regarding multiple product distribution licensing and...

2013-07-08 16:23:27

COLORADO SPRINGS, Colo., July 8, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company specializing primarily in cannabinoid formulation-based health and wellness solutions, is proud to announce that "American Drug War II: Cannabis Destiny" rated as the highest of all 2013 documentaries with a score of 9.7 out of 10. The film focuses on the failed U.S. drug war and its affect on a new generation of children. As IMDB states, "Director Kevin Booth navigates...

2013-05-20 08:28:10

DALLAS, May 20, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions through its Phytiva brand product lines is excited to confirm continued emphasis on new product development beyond recently announced European and extract-based lines. One of the several opportunities being explored by the Company is a new retail product line developed in conjunction with Steven B. Hopping, M.D., F.A.C.S., renowned cosmetic...

2013-05-15 16:27:21

DALLAS, May 15, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions through its Phytiva brand product lines is excited to announce the launch of its new website at www.phytiva.com. The website's design has been upgraded for a more interesting and effective viewing experience and a powerful Patient Resource Center for sharing of critical information. The Company launches the new website as it targets...

2013-05-15 08:32:45

DALLAS, May 15, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions through its Phytiva brand product lines is excited to announce at 11:00am PDT the launch of its new website at www.phytiva.com. The team has been working to create a website that provides self-medicated cannabinoid patients with an online center for information about cannabinoid solutions for critical ailments, as well as patient resources and...

2013-05-08 08:31:04

AMSTERDAM, May 8, 2013 /PRNewswire/ -- X-Change Corp (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions is pleased to announce the appointment of drs. Mario Lap as Director of European Operations for the Company and several Dutch subsidiaries that are being formed by the Company in the Netherlands. Mr. Lap brings to the Company a unique combination of expertise in Dutch and greater European medical cannabis law and policy as well as in the areas...

2013-05-06 12:27:14

European Line Release, Expansion of International Operations, Development of Supply Facilities, Focused Growth for Critical Ailment Formulations Aimed at Direct-to-Patient Instant Access Programs AMSTERDAM, May 6, 2013 /PRNewswire/ -- X-Change Corp (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions, is pleased to provide a weighted performance guidance report for Company shareholders and its patient-oriented interested parties. Chad S....